Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 210-214

  Maeda, Shin ^a,d   Yoshida, Haruhiko ^a   Matsunaga, Hironari ^b   Ogura, Keiji ^a   Kawamata, Osamu ^c   Shiratori, Yasushi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WAKUNAGA PHARMACEUTICAL CO LTD   (Japan)

^c SRL INC   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; AMOXICILLIN; BIOTIN; CLARITHROMYCIN; LANSOPRAZOLE; RIBOSOME RNA; STREPTAVIDIN;

ADULT; AGAR GEL DIFFUSION; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POINT MUTATION; PREFERENTIAL HOMODUPLEX FORMATION ASSAY; PREVALENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0033988147     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.1.210-214.2000     Document Type: Article

References (31)

1. Admek, R. J., S. Suerbaum, B. Pfaffenbach, and W. Opferkuch. 1998. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin - influence on treatment outcome. Am. J. Gastroenterol. 93:386-389.
2. Bazzoli, F., R. M. Zagari, S. Fossi, P. Pozzato, G. Alampi, and P. Siponi. 1994. Short term low dose triple therapy for the eradication of Helicobacter pylori. Eur. J. Gastroenterol. Hepatol. 6:773-777.
3. Debets-Ossenkopp, Y. J., M. Sparrius, J. G. Kusters, J. I. Kolkman, and C. M. Vandenbroucke-Grauls. 1996. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS. Microbiol. Lett. 142:37-42.
4. The European Helicobacter pylori Study Group. 1997. Current European concepts in the management of Helicobacter pylori infection. Gut 41:8-13.
5. Gotoh, A., Y. Kawakami, T. Akahane, T. Akamatsu, T. Shimizu, K. Kiyosawa, and T. Katsuyama. 1997. Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy. Microbiol. Immunol. 41:7-12.
6. Graham, D. Y., G. M. Lew, P. D. Klein, D. G. Evans, D. J. Evans, Z. A. Saeed, and H. M. Malaty. 1992. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann. Intern. Med. 116:705-708.
7. Hulten, K., A. Gibreel, O. Skold, and L. Engstrand. 1997. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob. Agents Chemother. 41:2550-2553.
8. Kawamata, O., H. Yoshida, K. Hirota, A. Yoshida, R. Kawaguchi, Y. Shiratori, and M. Omata. 1996. Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease A gene in clinically isolated bacterial strains. Biochem. Biophys. Res. Commun. 219:266-272.
9. Labenz, J., M. Stolte, G. H. Ruhl, T. Becker, B. Tillenburg, and G. Borsch. 1995. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 7:9-11.
10. Lind, T., S. Veldhuyzen, P. Unge, R. Spiller, E. Bayerdorffer, C. O'Morain, K. D. Bardhan, M. Bradette, and N. Chiba. 1996 Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1:138-144.
11. Lind, T., F. Megraud, P. Unge, E. Bayerdorffer, C. O'Morain, R. Spiller, S. Veldhuyzen, K. D. Bardhan, M. Hellblom, M. Wrangstadh, L. Zeijlon, and C. Cederberg. 1999. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 116:248-253.
12. Maeda, S., H. Yoshida, K. Ogura, F. Kanai, Y. Shiratori, and M. Omata. 1998. Helicobacter pylori-specific nested-PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 43:317-321.
13. Marais, A., L. Monteiro, A. Occhialini, M. Pina, H. Lamouliatte, and F. Megraud. 1999. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 44:463-467.
14. Midolo, P. D., J. R. Lambert, and J. Turnidge. 1996. Metronidazole resistance: a predictor failure of Helicobacter pylori eradication by triple therapy. J. Gastroenterol. Hepatol. 11:290-292.
15. Miyaji, H., T. Azuma, S. Ito, Y. Yamazaki, F. Sato, M. Hirai, Y. Kuriyama, T. Kato, and Y. Kohri. 1997. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment. Pharmcol. Ther. 11:1131-1136.
16. National Institutes of Health. 1994. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272:65-69.
17. Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136.
18. Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bebear, H. Lamouliatte, and F. Megraud. 1997. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob. Agents Chemother. 41:2724-2728.
19. Oka, T., H. Matsunaga, K. Tokunaga, S. Mitsunaga, T. Juji, and A. Yamane. 1994. A simple method for detecting single base substitutions and its application to HLA-DPB1 typing. Nucleic Acids Res. 22:1541-1547.
20. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, and J. H. Vogelman. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
21. Stone, G. G., D. Shortridge, J. Versalovic, J. Beyer, R. K. Flamn, D. Y. Graham, A. T. Ghoneim, and S. K. Tanaka. 1997. PCR oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41:712-714.
22. Taylor, D. E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 41:2621-2628.
23. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weldman, C. Fujii, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539-547.
24. van Zwet, A. A., W. A. de Boer, P. M. Schneeberger, J. Weel, A. R. Jansz, and J. C. Thijs. 1996. Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands. Eur. J. Clin. Microbiol. Infect. Dis. 15:861-864.
25. Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.
26. Versalovic, J., M. S. Osato, K. Spakovsky, M. P. Dore, R. Reddy, G. G. Stone, D. Shortridge, R. K. Flamn, K. Tanaka, and D. Y. Graham. 1997. Point mutation in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J. Antimicrob. Chemother. 40:283-286.
27. Walsh, J. H., and W. L. Peterson. 1995. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 333: 984-991.
28. Warren, J. R., and B. J. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 i:1273-1275.
29. Weldon, M. J., A. Broadbent, S. Chambers, R. Nistry, L. Ranganath, and S. R. Gould. 1996. A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. Aliment. Pharmcol. Ther. 10:279-283.
30. Wotherspoon, A. C., C. Doglioni, T. C. Diss, L. Pan, A. Moschini, M. de Boni, and P. G. Isaacson. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577.
31. Yoshida, H., K. Hirota, Y. Shiratori, T. Nihei, S. Amano, A Yoshida, O. Kawamata, and M. Omata. 1998. Use of a gastric juice-based PCR assay to detect Helicobacter pylori infection in culture-negative patients. J. Clin. Microbiol. 36:317-320.